Daniel Alvira

587 total citations
16 papers, 514 citations indexed

About

Daniel Alvira is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniel Alvira has authored 16 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniel Alvira's work include Cell death mechanisms and regulation (4 papers), Cancer-related Molecular Pathways (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Daniel Alvira is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Cancer-related Molecular Pathways (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Daniel Alvira collaborates with scholars based in Spain, United States and Sweden. Daniel Alvira's co-authors include Mercè Pallàs, Antoni Camins, Jaume Folch, Ester Verdaguer, Marc Yeste‐Velasco, Marta Tajes, Anna M. Canudas, Isidró Ferrer, Javier Cuesta and Francesc X. Sureda and has published in prestigious journals such as Journal of Biological Chemistry, Neuroscience and British Journal of Pharmacology.

In The Last Decade

Daniel Alvira

16 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Alvira Spain 13 243 132 124 105 83 16 514
M. G. R. PITTA United States 5 285 1.2× 97 0.7× 263 2.1× 211 2.0× 46 0.6× 5 694
Emmanuel Lambert France 5 307 1.3× 203 1.5× 235 1.9× 399 3.8× 55 0.7× 5 732
Natàlia Crespo‐Biel Spain 11 256 1.1× 212 1.6× 324 2.6× 56 0.5× 72 0.9× 12 607
Francesca-Fang Liao United States 11 377 1.6× 129 1.0× 228 1.8× 28 0.3× 72 0.9× 13 646
Sang‐Won Min United States 4 207 0.9× 63 0.5× 246 2.0× 88 0.8× 122 1.5× 4 514
Junbing Wu China 11 264 1.1× 135 1.0× 68 0.5× 31 0.3× 105 1.3× 14 512
Petronela Weisová Ireland 13 490 2.0× 182 1.4× 165 1.3× 26 0.2× 55 0.7× 17 755
Judith Purcell United States 8 730 3.0× 372 2.8× 95 0.8× 106 1.0× 84 1.0× 8 954
Jeffrey M. Harder United States 17 803 3.3× 170 1.3× 135 1.1× 112 1.1× 41 0.5× 22 1.4k
Diego E. Hernández Chile 7 364 1.5× 172 1.3× 182 1.5× 16 0.2× 53 0.6× 9 578

Countries citing papers authored by Daniel Alvira

Since Specialization
Citations

This map shows the geographic impact of Daniel Alvira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Alvira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Alvira more than expected).

Fields of papers citing papers by Daniel Alvira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Alvira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Alvira. The network helps show where Daniel Alvira may publish in the future.

Co-authorship network of co-authors of Daniel Alvira

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Alvira. A scholar is included among the top collaborators of Daniel Alvira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Alvira. Daniel Alvira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Alvira, Daniel & Laura Mondragón. (2015). Drug Delivery Strategies of Chemical CDK Inhibitors. Methods in molecular biology. 1336. 141–154. 2 indexed citations
2.
Alvira, Daniel, et al.. (2011). Inhibition of Protein-tyrosine Phosphatase 1B (PTP1B) Mediates Ubiquitination and Degradation of Bcr-Abl Protein. Journal of Biological Chemistry. 286(37). 32313–32323. 20 indexed citations
3.
Camins, Antoni, Javier Pizarro‐Delgado, Daniel Alvira, et al.. (2010). Activation of ataxia telangiectasia muted under experimental models and human Parkinson’s disease. Cellular and Molecular Life Sciences. 67(22). 3865–3882. 24 indexed citations
4.
Junyent, Fèlix, Daniel Alvira, Marc Yeste‐Velasco, et al.. (2010). Prosurvival role of JAK/STAT and Akt signaling pathways in MPP+-induced apoptosis in neurons. Neurochemistry International. 57(7). 774–782. 13 indexed citations
5.
Folch, Jaume, Daniel Alvira, Marta Tajes, et al.. (2009). Evaluation of transcriptional activity of caspase-3 gene as a marker of acute neurotoxicity in rat cerebellar granular cells. Toxicology in Vitro. 24(2). 465–471. 12 indexed citations
6.
Folch, Jaume, Marc Yeste‐Velasco, Daniel Alvira, et al.. (2009). Evaluation of pathways involved in pentachlorophenol-induced apoptosis in rat neurons. NeuroToxicology. 30(3). 451–458. 22 indexed citations
7.
Pallàs, Mercè, Javier Cuesta, Natàlia Crespo‐Biel, et al.. (2008). Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience. 154(4). 1388–1397. 99 indexed citations
8.
Alvira, Daniel, Marta Tajes, Ester Verdaguer, et al.. (2007). Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons. Neuroscience. 146(1). 350–365. 42 indexed citations
9.
Alvira, Daniel, Marc Yeste‐Velasco, Jaume Folch, et al.. (2007). Comparative analysis of the effects of resveratrol in two apoptotic models: Inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience. 147(3). 746–756. 80 indexed citations
10.
Alvira, Daniel, Marc Yeste‐Velasco, Jaume Folch, et al.. (2007). Neuroprotective effects of caffeine against complex I inhibition–induced apoptosis are mediated by inhibition of the Atm/p53/E2F‐1 path in cerebellar granule neurons. Journal of Neuroscience Research. 85(14). 3079–3088. 34 indexed citations
11.
Alvira, Daniel, et al.. (2007). Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease. Parkinsonism & Related Disorders. 14(4). 309–313. 53 indexed citations
12.
Alvira, Daniel, Ester Verdaguer, Marta Tajes, et al.. (2006). Evaluation of acute antiapoptotic effects of Li+ in neuronal cell cultures. Journal of Neural Transmission. 114(4). 405–416. 12 indexed citations
13.
Alvira, Daniel, Marta Tajes, Ester Verdaguer, et al.. (2006). Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease. Journal of Pineal Research. 40(3). 251–258. 62 indexed citations
14.
Verdaguer, Ester, Daniel Alvira, Andrés Jiménez, et al.. (2005). Inhibition of Multiple Pathways Accounts for the Antiapoptotic Effects of Flavopiridol on Potassium Withdrawal-Induced Apoptosis in Neurons. Journal of Molecular Neuroscience. 26(1). 71–84. 11 indexed citations
15.
Verdaguer, Ester, Daniel Alvira, Andrés Jiménez, et al.. (2005). Inhibition of the cdk5/MEF2 pathway is involved in the antiapoptotic properties of calpain inhibitors in cerebellar neurons. British Journal of Pharmacology. 145(8). 1103–1111. 24 indexed citations
16.
Pallàs, Mercè, Anna M. Canudas, Ester Verdaguer, et al.. (2005). Inhibitors of Cyclin-Dependent Kinases: Potential Drugs for the Treatment of Neurodegenerative Disorders?. 5(2). 101–109. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. G. R. PITTA Breakdown of academic impact, for papers by Emmanuel Lambert Breakdown of academic impact, for papers by Natàlia Crespo‐Biel Breakdown of academic impact, for papers by Francesca-Fang Liao Breakdown of academic impact, for papers by Sang‐Won Min Breakdown of academic impact, for papers by Junbing Wu Breakdown of academic impact, for papers by Petronela Weisová Breakdown of academic impact, for papers by Judith Purcell Breakdown of academic impact, for papers by Jeffrey M. Harder Breakdown of academic impact, for papers by Diego E. Hernández
Rankless by CCL
2026